For the first time, drugs that slow down memory and thinking decline in early Alzheimer’s disease have been approved by UK regulators. But research never stops. Here we explore the next wave of promising new drugs.

As part of the Alzheimer’s Society grant funding applications, we require a narrative CV to help us in the shortlisting process. Read on to learn more about how to write yours. 

We recognise the importance of the pharmaceutical and medical technologies industry in dementia research and have clear commitments for any work we undertake in partnership with the med-tech sector.

Is your sports club, members group or volunteer-led association looking to make a difference? We invite you to bring your members together and help raise vital funds to support people living with dementia.